Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD)

被引：2
|
作者：
Jilma, Bernd [1 ]
Gilbert, James C. [2 ]
Panicker, Sandip [2 ]
Parry, Graham C. [2 ]
Fillitz, Michael [3 ]
Thomas, Schenk [4 ]
Sillaber, Christian [5 ]
Bartko, Johann [1 ]
Jaeger, Ulrich [6 ]
机构：
[1] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
[2] True North Therapeut Inc, San Francisco, CA USA
[3] Hanusch Hosp, Vienna, Austria
[4] Univ Klinikum St Polten, Internal Med, St Polten, Austria
[5] Med Univ Vienna, Div Hematol, Dept Internal Med 1, Vienna, Austria
[6] Med Univ Vienna, Div Hematol & Hemostaseol, Vienna, Austria
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.2435.2435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2435
引用
收藏
页数：4
相关论文
共 22 条
  • [1] THE ANTI C1S COMPLEMENT ANTIBODY TNT009 INDUCES RAPID COMPLETE REMISSIONS OF ANAEMIA IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE
    Jaeger, U.
    Gilbert, J. C.
    Panicker, S.
    Parry, G. C.
    Fillitz, M.
    Schenk, T.
    Sillaber, C.
    Bartko, J.
    Jilma, B.
    HAEMATOLOGICA, 2016, 101 : 341 - 341
  • [2] TNT009, a monoclonal antibody inhibitor of C1s, induces a rapid and complete remission of anemia in primary cold agglutinin disease patients
    Panicker, Sandip
    Parry, Graham C.
    Fillitz, Michael
    Schenk, Thomas
    Sillaber, Christian
    Bartko, Johann
    Gilbert, James C.
    Jaeger, Ulrich
    Jilma, Bernd
    IMMUNOBIOLOGY, 2016, 221 (10) : 1170 - 1171
  • [3] Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease
    Roeth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Weitz, Ilene C.
    Yoo, Ronnie
    Jayawardene, Deepthi
    Vagge, Deepthi S.
    Kralova, Katarina
    Shafer, Frank
    Wardecki, Marek
    Lee, Michelle
    Berentsen, Sigbjorn
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1246 - 1253
  • [4] Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
    Roth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Lin, Stella
    Jiang, Xiaoyu
    Reuter, Caroline
    Hobbs, William
    Berentsen, Sigbjorn
    BLOOD, 2019, 134
  • [5] INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FROM THE PHASE 3 CARDINAL STUDY
    Roeth, A.
    Barcellini, W.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, T. H. Anderson
    Lin, S.
    Jiang, X.
    Reuter, C.
    Hobbs, W.
    Berentsen, S.
    HAEMATOLOGICA, 2020, 105 : S38 - S38
  • [6] Results from the phase 3 Cardinal study part A: Inhibition of complement C1s with Sutimlimab in patients with Cold Agglutinin Disease (CAD)
    Roeth, A.
    Barcellini, W.
    Sa, D. S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, Anderson T. H.
    Lin, S.
    Jiang, X.
    Reuter, C.
    Hobbs, W.
    Berentsen, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 177 - 177
  • [7] Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
    Jaeger, Ulrich
    D'Sa, Shirley
    Schoergenhofer, Christian
    Bartko, Johann
    Derhaschnig, Ulla
    Sillaber, Christian
    Jilma-Stohlawetz, Petra
    Fillitz, Michael
    Schenk, Thomas
    Patou, Gary
    Panicker, Sandip
    Parry, Graham C.
    Gilbert, James C.
    Jilma, Bernd
    BLOOD, 2019, 133 (09) : 893 - 901
  • [8] Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program
    Gelbenegger, Georg
    Schoergenhofer, Christian
    Derhaschnig, Ulla
    Buchtele, Nina
    Sillaber, Christian
    Fillitz, Michael
    Schenk, Thomas M.
    D'Sa, Shirley
    Cartwright, Ronwyn
    Gilbert, James C.
    Jilma, Bernd
    Jaeger, Ulrich
    BLOOD ADVANCES, 2020, 4 (06) : 997 - 1005
  • [9] Long term inhibition of complement C1s in patients with cold agglutinin disease: Results from a named patient program
    Gelbenegger, Georg
    Schoergenhofer, Christian
    Sillaber, Christian
    D'Sa, Shirley
    Fillitz, Michael
    Schenk, Thomas
    Gilbert, James C.
    Cartwright, Ronwyn
    Jilma, Bernd
    Jaeger, Ulrich
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S446 - S446
  • [10] Long term inhibition of complement C1s in patients with cold agglutinin disease: results from a named patient program
    Jilma, B.
    Gelbenegger, G.
    Derhaschnig, U.
    Sillaber, C.
    D'Sa, S.
    Fillitz, M.
    Schenk, T.
    Gilbert, J.
    Cartwright, R.
    Jaeger, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 9 - 9
123